Q1 2022 13F Holders as of 31 Mar 2022
-
Type / Class
-
Equity / Common Stock, $0.001 par value per share
-
Shares outstanding
-
43,411,663
-
Number of holders
-
94
-
Total 13F shares, excl. options
-
17,760,015
-
Shares change
-
+1,294,516
-
Total reported value, excl. options
-
$86,753,965
-
Value change
-
+$4,600,276
-
Put/Call ratio
-
51%
-
Number of buys
-
46
-
Number of sells
-
-35
-
Price
-
$4.88
Significant Holders of Cue Biopharma, Inc. - Common Stock, $0.001 par value per share (CUE) as of Q1 2022
110 filings reported holding CUE - Cue Biopharma, Inc. - Common Stock, $0.001 par value per share as of Q1 2022.
Cue Biopharma, Inc. - Common Stock, $0.001 par value per share (CUE) has 94 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 17,760,015 shares
of 43,411,663 outstanding shares and own 40.9% of the company stock.
Largest 10 shareholders include BlackRock Inc. (2,381,267 shares), Nantahala Capital Management, LLC (2,244,359 shares), VANGUARD GROUP INC (1,653,737 shares), Prosight Management, LP (1,510,282 shares), Slate Path Capital LP (1,483,619 shares), SANDERS MORRIS HARRIS LLC (873,021 shares), DIMENSIONAL FUND ADVISORS LP (741,903 shares), STATE STREET CORP (727,023 shares), Bleichroeder LP (552,000 shares), and GEODE CAPITAL MANAGEMENT, LLC (548,405 shares).
This table shows the top 94 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.